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Abstract
ST analysis of the fetal ECG as an adjunct to FHR monitoring in labour – a clinical validation. 
Norén Håkan 2008. Department of Obstetrics and Gynaecology, Sahlgrenska Academy at Göteborg 
University, Sahlgrenska University Hospital, S-413 45 Göteborg, Sweden.
The ability to make an accurate assessment of fetal well-being during labour is a great challenge. 
Animal and human studies have shown that fetal hypoxemia during labour can alter the shape of the 
fetal electrocardiogram (FECG) waveform, notable elevation of the T-wave and depression of the ST 
segment. A new medical device (STAN, Neoventa Medical, Mölndal, Sweden) has been developed to 
monitor the FECG during labour as an adjunct to continuous electronic FHR monitoring (CTG+ST 
analysis). Before a more general clinical use the technique has been the object of three randomised 
trials. The present thesis concerns the implementation of this new technique into clinical practice.
At Sahlgrenska hospital, Göteborg, Sweden, 4830 out of 14687 (32.9%) term deliveries were 
monitored between October 2000 and September 2002. While the number of monitored cases increased 
from 28.1% in the first year to 37.7% during the second year, the frequency of metabolic acidosis (pH 
<7.05 and BDecf >12mmol/l) decreased from 0.76% to 0.44% in all patients and from 1.12% to 0.56% 
in the CTG+ST monitored group assessed to be in need of close surveillance. The number of operative 
deliveries was unaltered (Paper I).
In a retrospective study at Varberg district hospital labour ward, covering the total population of 
deliveries during 2004 and 2005, 59% of the deliveries (1875/3193) were monitored with CTG+ST. 
The metabolic acidosis rate was 0.5%. Crash Caesarean sections (CS) were significantly reduced from 
1.5% in the conventionally monitored (CTG) group to 0.3% in the CTG+ST group (Paper II). It was 
concluded that the frequency of metabolic acidosis in this large number of deliveries from Göteborg 
and Varberg is the same as noted in the CTG+ST group in a Swedish randomised trial on CTG+ST 
analysis.
Cases originating from a European Union commission supported multi-centre study where CTG+ST 
had been used together with fetal blood sampling (FBS) were analysed. Of the 911 cases, 53 had cord 
artery pH<7.06 and 44 had cord artery pH 7.06 -7.09. These cases were analysed together with 97 
control cases. CTG+ST clinical guidelines identified all adequately monitored cases with metabolic 
acidosis requiring special neonatal care. These cases were identified at least 19 minutes prior to delivery. 
In 22 cases, FBS was obtained 13 (7-24) minutes after CTG+ST guidelines had indicated abnormality 
and in eight no ST changes had occurred at time of FBS. The corresponding FBS data were pH 7.10 
(7.01 – 7.15) and pH 7.21 (7.08 – 7.31), respectively, p=0.01. In cases of metabolic acidosis, scalp-pH 
fell 0.01 units per minute after a ST change rise had been recorded during second stage of labour. In 43 
out of 53 cases with cord artery pH <7.06 CTG + ST indicated intervention.  In five cases no ST data 
existed and in the rest of the cases there were no ST indications. One of these newborn had metabolic 
acidosis but was clinically unaffected (Paper III and IV).
The time factor, i.e, the time between onset of significant ST events and delivery can be illustrated 
by the observation that of those with CTG+ST events recorded within 16 minutes of delivery, 61% had 
cord artery pH ≥7.20. The corresponding figure for cases where CTG+ST indications occurred more 
than 16 minutes before delivery was 19% (OR 6.66, 2.29 – 19.86, p<0.001). 
In conclusion, these data indicate that ST analysis of the FECG identifies a term fetus exposed 
to hypoxia during labour in a reliable way. FBS has a role in fetal monitoring, e.g. when a CTG+ST 
recording starts late in labour with abnormal CTG.
Keywords: fetal ECG, ST analysis, electronic fetal monitoring, cardiotocography, fetal blood 
sampling, metabolic acidosis.
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Abbreviations
AS Apgar score
BDecf  base deficit
BE base excess
CTG  cardiotocography
CoE centre of excellence
CO2  carbon dioxide
CP  cerebral palsy
CNS central nervous system 
ECG electrocardiogram
ECF extracellular fluid
EFM electronic fetal monitoring
FECG fetal electrocardiogram
FBS    fetal blood sampling
FIGO International federation of Gynaecologists and Obstetricians
FTP failure to progress
GOT Göteborg
H+  hydrogen
HCO3 hydrogen carbonate
H2CO3 carbonic acid
H2O water
HIE  hypoxic ischemic encephalopathy
IUGR intrauterine growth retardation
K+  potassium ion
NICU neonatal intensive care unit
ODFD operative delivery for fetal distress 
OR odds ratio
pO2 partial pressure of oxygen
pCO2 partial pressure of carbon dioxide
RCT randomised controlled trial
SCBU special care baby unit
SD standard deviation
ST  ST segment of the electrocardiogram
STAN  fetal monitor with ST analysis
SVD spontaneous vaginal delivery
VE vacuum extraction 
QI  quality improvement 
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Introduction
Fetal monitoring during labour constitutes a challenge in information management. 
Until today labour staff has managed this complex situation by visual analysis of a 
host of information. Recent developments have identified the possibility of not only 
adding new information from ST waveform analysis of the fetal electrocardiogram 
(FECG) but also applying computer assisted ST data interpretation thereby reducing 
ambiguity and improving coherence with clinical guidelines.
Adverse events in early life are known to have an impact on both child development 
and long-term adult health. Perinatal brain injury in particular constitutes a major 
clinical hazard. Hypoxic-ischemic brain injury as a result of oxygen deficiency 
(asphyxia) during labour at term continues to be a problem. Ambiguity in interpreting 
CTG patterns is one factor behind ’defensive medicine‘ and increasing operative 
intervention rates. Clearly, this is not a situation that will satisfy anyone and we 
should consider what measures can be taken to improve perinatal outcome. Such 
an analysis would include the application of physiological models to enhance the 
interpretation of the FECG during delivery.
A paradigm shift from a screening to a diagnostic capacity requires not only new 
knowledge and new technology. Equally important is the management of clinical 
data with feature extraction to provide user support, identify short comings and 
stimulate learning in a wide sense. All of these are necessary to enable accurate and 
safe usage of  the routinely available FECG signal during the most high risk situation 
– the delivery. 
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Background
Intrapartum monitoring technologies
Recording the fetal heart rate (FHR) has been standard clinical practice for more 
than 150 years. The wooden Pinard’s stethoscope was the first technology to be 
introduced and is still in clinical usage by labour staff. However, it only provides 
intermittent information on the number of heart beats per minute. A fetal scalp 
electrode was developed in the beginning of the 1960s and allowed for a continuous 
FHR trace to be recorded during labour after rupture of membranes. It was believed 
that the provision of continuous information would enable clinicians to detect babies 
exposed to oxygen deficiency. Electronic fetal monitoring (EFM) was developed 
with the introduction of cardiotocography (CTG) technology, which rapidly gained 
clinical acceptance and commercial success. 
In many countries, information on the status of the fetus during delivery has up 
until now been obtained using CTG alone or with the addition of fetal blood sampling 
(FBS) or fetal pulse oximetry. 
Cardiotocography, CTG
Since its introduction in the early 1970s, CTG monitoring of the fetus has 
become standard clinical practice. CTG is the continuous recording of FHR and 
uterine activity. The FHR can be recorded either by direct application of a fetal scalp 
electrode or from an ultrasound transducer positioned on the abdomen of the mother. 
Uterine activity is assessed from either a transducer placed on the abdomen of the 
mother or by placing a pressure sensitive catheter alongside the fetus in the uterine 
cavity. The healthcare provider visually assesses the recording in order to identify 
situations of oxygen deficiency.
Since the introduction of CTG monitoring relatively little has been added to the 
understanding of the physiological mechanisms involved in FHR changes related 
to fetal hypoxia. The benefit of CTG is to identify the normal progress of labour. 
However, 30 to 40% of fetuses may display CTG changes that require further 
analysis and expertise to interpret (Steer et al 1989). Even with such expertise, 
cases are missed, as measurement of the FHR alone does not have the capacity 
to provide information as to what extent the fetus is adapting normally during the 
labour process. This may mean unnecessary interference with normal labour, such 
as FBS or emergency operative deliveries (such as Caesarean section (CS), vacuum 
extraction (VE) or forceps deliveries), which may result in an increased health risk 
for mother and fetus and an increase in healthcare expenditures.
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Fetal blood sampling (FBS)
The FBS technique involves taking a sample of blood from the fetus by puncturing 
the fetal scalp whilst in the birth canal and measuring the pH/lactate of the blood. 
This method of fetal monitoring was introduced at the same time as EFM. FBS is not 
in general use in many countries and the technique does not provide information on 
a continuous basis and is cumbersome to perform. However, it is still to be regarded 
as the reference method to indicate the need for intervention and immediate delivery. 
These qualifications have been reached with few studies to validate its relationship 
to perinatal asphyxia (NICE 2007).
Fetal pulse oximetry
Fetal pulse oximetry focuses on recording the actual level of fetal hypoxemia 
(reduction of oxygen in the arterial blood). Current literature shows diverging views 
on the usefulness of the information made available from fetal pulse oximetry during 
labour. Two randomised controlled trials (RCT) have been performed. The first 
trial was only powered enough to allow for assessment of reduction in CS for non-
reassuring fetal status. This was achieved but the overall CS rate did not decrease 
and the issue was raised why CS for failure to progress (FTP) would increase and 
a second RCT was undertaken. This study was ended prematurely as an interim 
analysis showed very high CS rates and no improvements (Bloom et al 2006).
Perinatal outcome
For many years, it was assumed that birth asphyxia was the principal cause of 
cerebral palsy (CP). Indeed, when CTG was introduced in 1970s it was hoped that 
this technique would reduce the incidence of CP and mental retardation by 50%. 
Disappointingly, the results of randomised trials showed little or no benefit with 
respect to long-term neurological outcome, despite widespread use of the CTG 
(Afirevic et al 2006). Studies have shown that around 3-28% of cases of CP are 
associated with intrapartum asphyxia (Nelson 203).
The CTG is an integral part of intrapartum care in most delivery wards and it 
is helpful in identifying asphyxiating conditions during labour in a small group 
of babies at risk of death or irreversible brain injury. CTG remains the central 
documentary evidence of all claims for fetal asphyxia. In a review of 110 cases 
of obstetric litigation for CP, Symonds and Senior (1991) found that 70% of these 
claims were based on abnormalities of the CTG and their interpretation.
An effect of the increasing number and costs of obstetric claims has been an 
escalating number of CS performed. During the last ten-year period, CS rates in 
England have doubled to approximately 20% of all deliveries. When questioned in 
a survey (Churchill et al 2006), 47% of obstetricians attributed the rise in the CS 
rate to ‘medico-legal-reasons’. According to another survey, 82% of physicians gave 
avoidance of medical negligence claims, as a reason for adopting procedures such as 
CS (Jones and Morris 1989). 
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EFM is applied in 75% of deliveries (Boehm 1999) in the US and there is evidence 
to show that the operative delivery rates are significantly increased with the use of 
EFM especially if FBS is not used as an adjunct to establish the fetal condition 
(Thacker et al 2001). The UK fourth ‘Confidential inquiries into Stillbirths and 
Deaths in infancy’(1995)  analysed the intrapartum deaths that were due to asphyxia 
in babies greater than 1500 g with no chromosomal or congenital malformation. The 
conclusion was that 50% of the deaths could have been avoided if an alternate care 
had been provided. The reasons identified for the poor outcomes were; inability to 
interpret CTG, failure to incorporate the clinical picture, delay in taking appropriate 
action and poor communication. This is not entirely surprising as the model of FHR 
interpretation is largely based on empirical observations of thousands of hours 
of recordings during human labour (Hon 1967). Large intra-and inter-observer 
differences in the interpretation of CTG recordings have been reported and even 
amongst experts (Nielsen et al 1987, Donker el al 1993, Bernardes et al 1997).
In their recent analysis, Amer-Wåhlin and Dekker (2008) states that CTG 
will always be a nonspecific method, currently dependent heavily on subjective 
interpretation. Thus, the labour ward staff (and the fetus) remains at risk for wrong 
or delayed action as clear-cut information is not available. Only with the addition of 
non-subjective information will the risk decrease.
Acid Base 
A central component in any attempt to reassess quality of care is the availability 
of marker of potentially adverse outcome. The choice of a marker has to be done 
with care. It has to be possible to obtain the information routinely, preferably during 
the perinatal period. It should have a high specificity and a ’reasonable‘ prevalence. 
From these prerequisites follows that outcome measures such as perinatal mortality, 
CP rates and even hypoxic ischemic encephalopathy (HIE) would be too rare and 
require too many resources to be obtained. Umbilical cord acid-base analysis has 
become part of routine care and serves as a quality measure as well as to provide risk 
assessment. 
Acidosis and neurological symptoms during the neonatal period
In a study by Low et al  (1994) as many as 61% of 59 term infants with metabolic 
acidaemia (buffer base <30 mmol/l) had encephalopathy. In a Swedish study 
(Ingemarsson et al 1997) ten of 154 infants (6.5%) with umbilical artery pH <7.05 
had neonatal cerebral complications, comparable with the rate in a study by Fee et al 
(1990), where six of 110 infants with cord artery pH <7.04 had encephalopathy. In 
a study by Nagel et al (1995) 30 infants with cord artery pH <7.0 were followed up 
for one to three years. Of the 28 infants who survived the neonatal period, only one 
had a mild motor developmental delay. Dennis et al (1989) compared infants with 
acidaemia at birth with non-acidotic babies having normal Apgar scores, and with 
low Apgar scores, for performance in neuro-developmental tests at age 4.5 years. 
They found no association between acidosis and neuro-developmental function in 
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contrast to the findings of Ingemarsson et al (1997). 
The reason for the discrepancy may be related to the cause of the development of 
acidaemia and acidosis. The appearance of a metabolic or respiratory acidaemia is a 
consequence of a decrease in placental blood flow with decreased gas exchange. A 
respiratory acidaemia is caused by a decrease in the transport of carbon dioxide (CO2) 
from the fetus to the mother. CO2 is produced in large amounts in the cellular energy 
yielding metabolic processes and a continuous placental blood flow is required to 
avoid CO2 accumulation. If this occurs, CO2 is converted to hydrogen ions, some 
of which become free and will cause a rapid decrease in pH and a respiratory 
acidaemia. 
Metabolic acidosis should be regarded as an active response to hypoxia, whereby 
anaerobic metabolism generates lactic acid. From this process, the acid component 
– the proton (H+) is buffered in the tissues and the base – lactate accumulates until it 
gets metabolised.       
Respiratory and metabolic acidaemia has different origins and means different 
things to the fetus. A respiratory acidaemia belongs to normal delivery; it emerges 
rapidly and disappears rapidly with the first few breaths of air. Very high CO2 
concentrations may delay the onset of spontaneous respiration. 
Metabolic acidaemia carries a risk for the tissues being affected. Metabolic 
acidaemia requires time to develop and it remains for longer periods of time. 
Furthermore, repeated episodes may add to each other thereby causing a reduction 
in the safety margins with a decrease in buffering capacity.
Metabolic acidosis is calculated from algorithms using pH and pCO2. There are 
two alternatives (Figure 1), the first developed by Siggaard Andersen in 1963, the 
Alignment nomogram where base deficit (BDecf) was calculated using the blood 
buffers only. This algorithm was found to overestimate the metabolic acidosis 
component in case of a mixed acidaemia. A second algorithm was therefore 
presented in 1971 (Siggaard-Andersen 1971), the ‘Acid-Base Chart’ where changes 
in extra-cellular fluid (ecf) buffers were calculated, thereby avoiding the impact of 
a respiratory acidosis (always accompanying an umbilical cord metabolic acidosis) 
on BDecf calculations. Figure 2 illustrates the principles of acid-base alterations in 
connection with the development of respiratory acidaemia. The increase in plasma 
bicarbonate (HCO3
-) causes a shift into the extravascular space and a loss of buffers 
from the blood compartment. By definition this would mean metabolic acidosis in 
the blood compartment, corrected for by including the whole extracellular space in 
the calculation of buffer distribution. Unfortunately, commercially available blood 
gas machines have not adopted Siggaard-Andersen ‘Acid-Base Chart’ algorithms. 
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Figure 1. The two Acid base charts developed by O Siggaard-Andersen.
The implication of this is that metabolic acidosis in newborn becomes more 
frequent as a high pCO2 will cause a falsely low base excess (Rosén and Murphy 
1991).
The cut-off point for pathological fetal acidaemia correlating with an increasing 
risk of neurological deficit has been set to a pH of less than 7.00 and a base excess 
(BE) of less than -16 mmol/l (Goldaber et al 1991, Winkler et al 1991).  In the 
literature, the level mostly used as diagnostic criterion is 12 mmol/l (Maclennan1999). 
If umbilical blood or neonatal blood gas data do not exist, it is impossible to be 
certain of a causative mechanism. If records of both arterial and venous umbilical 
gases exist, then a difference in BDecf of >3 mmol/l suggests an acutely developed 
metabolic acidosis with the artery having the highest BDecf (Sundström et al 2000).
 
Figure 2. Principles of acid-base changes in connection with respiratory acidaemia. Modified from 
Sundström et al 2000.
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Assessment of acid base data
The process of obtaining and analyzing cord samples for acid base data analysis 
have previously been validated (Westgate et al 1994) and methodological issues have 
been identified. One such area is erroneous pCO2 readings. A falsely low pCO2 will 
cause a falsely high calculated BDecf. The simplest way to determine the accuracy 
of a set of cord samples is to verify that the cord artery sample (lowest pH) should 
always have the highest pCO2. If that is not the case, the sample will not accurately 
reflect the acid base status. 
In case the cord samples are accurately obtained, BDecf in the artery and vein may 
be used as markers of the duration of hypoxia (Westgate et al 1994). A high BDecf in 
the cord artery but a normal in the cord vein would indicate a short lasting hypoxic 
process. When both the artery and vein indicate metabolic acidosis, an increased risk 
for neonatal symptoms and persistent hypoxic tissue damage would be expected.
Hypoxia is associated with a decrease in placental blood flow, and as a consequence 
there may be situations where blood is available in the vein only. A cord vein sample 
indicating metabolic acidosis should be regarded as a significant finding.
Obviously there are situations where no cord data are available at all, but still 
the newborn is affected by hypoxia and metabolic acidosis. These are cases where 
the newborn shows low Apgar at 5 minutes, requires active resuscitation, and 
shows metabolic acidosis/lactate rise in samples obtained immediately post partum. 
Furthermore, these neonates have clinical symptoms and often require buffering. 
In summary: 
For an unaffected newborn to be diagnosed with sustaining metabolic acidosis,  –
both cord artery and vein samples are required with the cord artery sample 
showing a lower pH and higher pCO2.
In case only one sample is available, it should be treated as a venous sample  –
and in case of metabolic acidosis the sample indicates a more substantial 
risk.
Even in case of no cord acid base data being available, the newborn may still  –
be diagnosed as having metabolic acidosis, provided it is affected and there 
are acid base data or lactate data obtained within the first hour to indicate 
metabolic acidosis.
Neonatal metabolic acidosis is defined as newborns with metabolic acidosis (cord 
sample or immediate neonatal finding) where the infant has developed symptoms 
(neurological, cardiorespiratory, metabolic) requiring special neonatal care.
Considerations when analyzing outcome
Consensus has been reached regarding the basic requirements for the diagnosis 
of intrapartum asphyxia (MacLennan 1991) Cord artery metabolic acidaemia of pH 
<7.00 and base deficit ≥12 mmol/l is defined as a biochemical marker of asphyxia. 
Unfortunately, this international consensus statement does not specify what base 
deficit algorithms should be used. 
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The BDecf estimation of metabolic acidosis and the chosen cut-off of cord artery 
pH <7.05 and BDecf >12 mmol/l has been used in most of the research on ST analysis 
performed after 1991. This identifies fetuses with a significant metabolic adjustment 
to hypoxia without being clinically affected, and serves as a relevant biochemical 
marker. It was confirmed in the Nordic study where ten of the 15 fetuses with cord 
metabolic acidosis had normal neonatal periods (Amer-Wåhlin et al 2002). The 
range of cord artery pCO2 readings showed that the metabolic acidosis was always 
combined with a respiratory acidaemia, thus verifying the importance of using BDecf 
algorithms including buffer distribution in the whole of the ecf-compartment.
Additional information and analysis of the FECG  
bioprofile 
The aim of fetal monitoring during labour is to identify fetuses at risk of an 
adverse outcome based on our ability to understand what is happening and how the 
fetus reacts to stress before it becomes a risk situation. It is only when adverse events 
and patterns can be accurately understood and analysed, that there is an opportunity 
to improve data interpretation clinically.
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Figure 3. A sequence of the fetal ECG including its components and their physiological relevance.
The fetal ECG and its physiology
The ECG reflects the summation of electrical events within the myocardial cells, 
as recorded from the body surface. Electrical changes seen on the surface occur 
in relation to changes in action potentials in the ventricular myocardium over 
time. In a normal healthy myocardium, the cells are in a polarized state (i.e. equal 
number of positive and negative charges) during diastole with an accumulation of 
positive charges, which is balanced by an equal number of negatively charged ions, 
extracellular electrons. This is the normal resting state until depolarization occurs. 
At this point the distribution of negative and positive charges is reversed by a self-
propagating wave from cell to cell through a ’battery condition‘; if the outer cell is 
positive and its adjacent cells are negative a local current will flow. The P and QRS 
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waves (Figure 3) are the resulting electrical activity produced by the propagation 
of the depolarisation wave. The T wave represents the time difference between 
repolarisation of different parts of the myocardium. 
Figure 4. Principles of how to calculate the T/QRS ratio and the physiology behind different ST 
patterns.
The sino-atrial node controls the action of the heart and the cells in this node 
are controlled by vagal and sympathetic nerves as well as by hormones such as 
adrenaline. The P wave configuration and time constants are affected by changes 
in the autonomic nervous system controlling part of the heart pump function. The P 
wave of the ECG (Figure 4) corresponds to the contraction of the atrium. The next 
sequence is the contraction of the ventricles, represented by the waves Q, R and S. 
The generation of these waves is a passive event and thus very stable and easily 
detected which makes it well suited for FHR recording.
The significance of FECG changes 
PR time interval
Hypoxia may cause an alteration in the PR time with a PR shortening in spite of 
a RR lengthening, but this is more related to the fetal heart attempting to preserve 
an optimal filling of the atrium in situations of a decrease in blood returning to the 
heart (Widmark et al 1992, Luzietti et al 1997). The significance of a sequence of PR 
shortening in connection with a lowering of the heart rate (bradycardia) would be to 
identify a vagal dominance in contrast to a direct depressive hypoxic effect.
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Q-T time interval
In intrapartum hypoxia, resulting in metabolic acidosis, a significant shortening 
of the fetal QT interval is present, also when the QT time is corrected for changes in 
heart rate. The observation of a shortening QT interval during hypoxia provides us 
with additional information on the condition of the fetal myocardium and the ionised 
calcium fraction affecting the pumping function (inotropic response) of the working 
heart (Oudijk et al 2004).
ST changes
The ST segment and T wave relate to the repolarisation of myocardial cells 
in preparation for the next contraction. This repolarisation process is energy 
consuming. An increase in T wave height occurs when the energy balance within 
the myocardial cells is threatened. During hypoxia this balance becomes negative 
and the cells produce energy by the β-adrenoceptor mediated anaerobic breakdown 
of glycogen reserves. This process not only produces lactic acid but also potassium 
ions (K+) which affect myocardial cell membrane potential and cause a rise of the 
ST waveform (Fenn 1939).
When energy balance cannot be maintained by vasodilatation or anaerobic 
metabolism, ischemia occurs in the endocardium. This will alter the sequence of 
repolarisation changing myocardial cell potentials and thus the direction of the 
current flow. A depression of the ST segment with or without negative T wave will 
occur (Figure 3) (Wohlfart 1987).
The maintenance of fetal myocardial function and survival during hypoxia depends 
on myocardial glycogenolysis as described by Dawes et al (1959). With increasing 
glycogenolysis, there is a further increase in T-wave amplitude (Rosén and Isaksson 
1976) and the correlation between the rates of glycogenolysis and increase in T/QRS 
has been described as linear (Hökegård et al 1981). 
Role of β-adrenoceptor activation
Apart from hypoxia, myocardial glycogenolysis could be activated 
pharmacologically by administrating β-adrenoceptor activating agents enhancing 
myocardial work performance. The relationship found between increase in myocardial 
work during hypoxia and the T wave height is illustrated in Figure 5. 
An important aspect of fetal response to hypoxia is the marked surge of 
catecholamines. Figure 6 shows the observations made in relation to the level of 
acidaemia, concentrations of catecholamines and T/QRS. Thus, it appears as if during 
moderate hypoxemia the appearance of an increase in T wave amplitude is related to 
the adrenaline surge, β-adrenoceptor activation and myocardial glycogenolysis and 
indicating fetal myocardial metabolic reactivity.
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Figure 5. A plot of T/QRS and myocardial work load index data in the fetal sheep obtained during 
hypoxia in connection with exogenous β-mimetic (terbutaline) infusion to the ewe. ‘MVO2’ defined as 
mean arterial blood pressure x cardiac output x myocardial contractility (max dP/dt) (Dagbjartsson 
et al 1989).
ST depression/negative T waves indicates an imbalance between endo- and 
epicardium: the perfusion pressure of the endocardium is always the lower at 
the same time as the mechanical strain is always the larger causing delay in the 
repolarisation (recovery) phase. This means that unless the myocardium is generally 
activated (β-receptor activation and enhanced Frank-Starling relationship, i.e. the 
ability of the myocardium to respond to volume load), a decrease in performance for 
whatever reason, may cause ST depression. Thus, not only hypoxia per se may cause 
ST depression as a sign of mal-adaptation, but also factors substantially altering the 
balance and the performance characteristics within the myocardial wall. So far a 
number of clinical situations have been associated with ST depression/negative T 
waves such as prematurity, infections, maternal fever, myocardial dystrophy and 
cardiac malformations (Rosén 2001). Yli and colleagues have recently documented 
the more frequent occurrence of ST depression in fetuses from mothers with diabetes 
mellitus, a disorder known to be associated with fetal myocardial dystrophy (Yli et 
al 2008).
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Figure 6. Changes in artery pH, plasma adrenaline concentration and T/QRS in connection to 60 
minutes hypoxia induced by letting the ewe breath a 7% oxygen gas mixture. Solid lines indicates 
the group of fetuses (n=10) that responded with an increase in T wave amplitude and dashed lines 
indicate group of fetuses with no ST change in response to hypoxia. The level of significance between 
the groups are indicated (**p<0.01). Data modified from Rosén et al 1984.
The relationship between gestational age and hypoxia have recently been 
elucidated by Mallard‘s group, by observing the type of ST patterns emerging in 
connection with cord occlusion and endotoxin administration in the mid gestation 
fetal lamb (Welin et al 2005). During prolonged cord occlusion, the mid-gestation 
fetal sheep has the capacity to react to asphyxia with a significant increase in the 
amplitude of the ST wave form together with an augmentation of blood pressure, 
which then subsides as the asphyxia continues. The appearance of negative ST 
segment appears to signify significant cardiac dysfunction with hypotension. 
The same group has recently been able to study the impact of endotoxemia (Blad 
et al 2008). The responses to lipopolysaccharide endotoxin developed gradually 
over several hours and were the opposite of those after asphyxia (hypotension, 
tachycardia and ST depression/negative T waves). The ST depression/negative T 
wave changes may represent reduced capacity of the myocardium to serve as a pump
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Principles of alterations in the Frank-Starling relationship with 
immaturity, hypoxia and infections
Adult heart
Fetal heart 
with ST rise
Adrenaline surge
Fetal heart at rest
Hypoxia, Infection, Immaturity
Fetal heart with ST 
depression/negative T
Stroke volume
End diastolic pressure
Figure .7 Illustrations of changes in the Frank-Starling relationship in connection with different 
ST patterns (Rosén, personal communication). 
Identification of specific clinical guidelines and  
construction of systems to support the clinician
The initial phase of the clinical work with ST analysis between 1979 and 1989 
focused on the verification of the experimental findings. Mode of recording the 
FECG as well as the relationship to biochemical markers was investigated. Lilja et 
al (1985) showed that two scalp electrodes provided a sufficiently stable signal and 
a linear correlation was found between T/QRS ratios obtained within 30 minutes of 
delivery and cord lactate values (r=0.58, p<0.01).
An important aspect was the identification of index cases, e.g. cases that developed 
signs of hypoxia, and the extent to which ST waveform changes would also be 
present. Figure 8 shows a recording from one of the index cases of intrapartum 
hypoxia displaying a marked rise in T wave height and T/QRS ratio during second 
stage of labour. A combination of respiratory and metabolic acidosis can be noted.
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Figure 8. A sample of a combined CTG +ST analysis prototype recording showing an increase in 
T/QRS ratio with abnormal CTG patterns. Recording obtained by H Lilja, Sahlgren’s University 
Hospital, Göteborg in 1987.
The technology applied in these early stages has been described by Rosén and 
Lindecrantz (1989). Despite the limitations in signal processing capacity it was 
shown that the ST analysis model of recording and processing the FECG provided ST 
waveform changes identical to those recorded during experimental hypoxia. These 
findings were further analysed by Arulkumaran et al (1990). Of 201 patients recorded 
during labour, nearly 45% had suspicious or abnormal FHR traces while only 27% 
had T/QRS ratio greater than 0.25 (mean +2 SD). A normal T/QRS ratio identified 
99% of fetuses with normal buffering capacity in cord artery blood. Acute hypoxia 
was recognized by the rapid rise in T/QRS. It was also shown that the specificity of 
T/QRS to identify fetuses at risk increased by combining the ST waveform analysis 
with FHR changes.
These data formed the basis for the first CTG+ST clinical guidelines, refined 
and validated in the Plymouth RCT (Westgate et al 1993). The guidelines contain 
the combination of CTG and ST analysis. The experimental data had clearly shown 
that ST analysis on its own provided information on the ability of the fetus to handle 
hypoxia. At the same time experimental data had also shown that β-adrenoceptor 
activation without hypoxia could institute ST elevation and it appeared logical to 
assume that there would be instances where the external forces (squeezing and 
squashing) during labour would cause catecholamine release, increased T/QRS ratio 
and a very reactive CTG with no evidence of intrapartum hypoxia.
24
These early studies also showed that the fetal reactions to hypoxia vary over time 
and a fetus exposed to long-term hypoxia may react differently as compared to the 
previously healthy fetus exposed to an acutely emerging hypoxic episode during 
second stage of labour. 
Furthermore, the fetal adaptation to chronic hypoxia means a gradual decrease 
in fetal reactions. The same vigour in the adaptive changes in the myocardial 
metabolism with a long lasting hypoxic event as compared with an acutely emerging 
event should not be expected. In such a situation, a CTG pattern without any signs 
of reactivity and heart rate variability, i.e. a preterminal trace, would be the most 
relevant finding. 
It is also possible for a fetus down regulating its activities (hibernating) in response 
to a long-term stress in which case the loss of signs of FHR reactivity would be the 
expected finding with little or no ST changes. 
Cord artery pH is a robust parameter that has been shown not to have a normal 
distribution, as there is a cohort of babies in the low pH range (Westgate and Greene 
1994). It appears as if this cohort may be identified from CTG+ST analysis. Data 
from the Plymouth RCT (Westgate et al 1993) showed that cases with ST elevation 
and abnormal CTG all had cord artery pH ≤7.15. In the Nordic observational study 
(Amer-Wåhlin et al 2002), 86% of the cases where the CTG+ST clinical guidelines 
called for intervention, the cord artery pH was <7.15. The increased sensitivity to 
detect a lowering of cord artery pH may be accounted for by the improvements 
in signal quality and the ability of the technology to more accurately identify ST 
changes and ST depression at an earlier stage of hypoxia.
The Plymouth RCT (Westgate et al 1993) demonstrated that the CTG by itself 
provided information on the fetal situation in as much as there was a significant 
decrease in cord artery pH in combination with an increase in severity of the CTG 
pattern. The pH decreased from a mean value of 7.26 with a normal CTG to 7.21 
when the CTG became intermediate and was reduced to 7.14 with an abnormal 
CTG. 
Clinical verification
The Plymouth RCT
With the need to provide scientific evidence of the clinical value of CTG+ST 
waveform, a large RCT was conducted in the non-academic unit at Freedom Fields 
Hospital in Plymouth (Westgate et al 1993). In 1990, the labour ward in this hospital 
was one of the largest in England and it was thought to reflect the level of care seen 
in a busy labour ward. The design and size of the trial was such that no research staff 
would oversee every case. The ordinary staff handled the cases thereby enabling the 
trial to better reflect a situation of general clinical use of CTG+ST analysis. Although 
it was understood that further technological developments would be required, STAN 
8801 (Cinventa Medical, Mölndal, Sweden) provided a technique that could be used 
with appropriate training and motivation. 
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The trial met with the primary aim of showing a reduction in operative deliveries 
for fetal distress without increasing the risk of newborns suffering from hypoxia. 
There was a 46% reduction (p < 0.001, odds ratio 1.85 [1.35-2.66]) in operative 
deliveries for fetal distress (ODFD) and a trend to fewer metabolic acidosis (p = 
0.09, odds ratio 0.38 [0.13-1.07]) and fewer low five-minute Apgar score cases (p = 
0.12, odds ratio 0.62 [0.35-1.08]) in the ST+CTG arm. 
The trial tested the hypothesis that a combination of CTG+ST analysis compared 
to CTG only would reduce ODFD without placing the fetus at risk. If the primary 
endpoint had been to obtain a reduction in metabolic acidosis rate, the 2400 cases 
enrolled in the trial were not sufficient as 3600 cases would have been required to 
demonstrate a 50% reduction in cord artery pH <7.05 and BDecf >12 mmol/l (β = 
0.20, α = 0.05, incidence 1.3%). Thus, the next step in the clinical verification of 
CTG+ST analysis would be to test the ability to improve outcome by lowering the 
incidence of metabolic acidosis.
The European Community and Nordic studies
The European Community descriptive multi-centre trial was initiated to validate 
signal processing (Luzietti et al 1999). The STAN 8801 model was used while 
linked to a computer for data acquisition. Considerable improvements in signal 
processing occurred after the study was completed, when digital signal processing 
was introduced. 
A second descriptive study in 12 Nordic labour wards (Amer-Wåhlin et al 2002) 
was therefore initiated. It included 574 cases recorded using a new prototype of the 
STAN monitor (Neoventa Medical AB, Mölndal Sweden) where FECG data was 
stored for subsequent computerised ST analysis.
In the Nordic study, 15 cases were identified as being exposed to intrapartum 
hypoxia. Five cases had neonatal neurological symptoms (increased neuromuscular 
tone: 2 cases, seizures within 24 hours: 3 cases), all had abnormal FECG findings 
during first stage of labour. Another ten cases had cord metabolic acidaemia only; 
two had changes in first stage of labour and the remaining eight showed ST changes 
during active pushing in second stage only. 
An increase in baseline T/QRS occurred in 12 of the 15 cases exposed to 
intrapartum hypoxia. The range of increase in baseline T/QRS was 0.07 to 0.20 
with an average increase of 0.13. One case displayed an episodic increase in T/QRS 
during the last nine minutes of labour; one case showed consistent ST depression 
with negative T waves and the final case had a preterminal CTG. Thus, the CTG+ST 
clinical guidelines were found to provide adequate support in identifying intrapartum 
hypoxia.
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The Swedish RCT
The aim of the Swedish RCT (Amer-Wåhlin et al 2001) was to verify the ability 
of the CTG+ST to improve neonatal outcome by lowering the incidence of metabolic 
acidosis. The Plymouth RCT (Westgate et al 1993) was a single centre study, but the 
Swedish trial was designed as a multi-centre trial in three busy labour wards. 
The trial included 4966 women with term fetuses in cephalic presentation during 
labour after a clinical decision had been made to apply a fetal scalp electrode for 
internal CTG recording. Patients were randomised to CTG+ST analysis or to CTG 
only. The trial was designed with a power to assess potential improvements in neonatal 
outcome. The design also allowed testing for the effects of growing experience with 
the new ST analysis technology in the three labour units with cases managed by 
more than 300 midwifes and physicians.
Table I shows the outcome with regard to the primary aim of the trial, a more than 
50% reduction in cord artery metabolic acidosis. When the basic recommendations 
of starting a recording in first stage of labour and maintaining data collection within 
20 minutes of delivery (‘adequate recordings’) were followed, further improvements 
were noted. 
Mode of analysis CTG+ST CTG
OR,
95% CI,
p-value
Intention to treat
15
0.69%
31
1.49%
0.46
0.25-0.86
0.02
No of cases 2159 2079
Adequate recordings
11
0.57%
27
1.44%
0.39
0.19-0.79
0.01
No of cases 1926 1871
Table I. Numbers and rates of cases with cord artery metabolic acidosis.
The trial showed a significant reduction in operative ODFD from 9.3% to 7.7% 
(OR 0.81, p=0.047). Table II shows the ODFD rates related to the two phases of the 
trial. It was only with growing experience and the introduction of structured case 
discussions during the second phase of the trial that a positive effect on ODFD rates 
was noted. 
The main aim of the trial was to show improvements in neonatal outcome using 
cord artery metabolic acidosis as a marker of adverse situations. The reason for 
choosing a marker such as BDecf has previously been discussed in this thesis. During 
the second phase of the trial, a reduction in cord artery metabolic acidosis from 
1.48% to 0.50% was noted (OR 0.33, p=0.045).
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Intention to treat CTG+ST CTG
OR,
95% CI,
p-value
First phase 114
8.6%
104
8.3%
1.03
No of cases 1333 1250
Second phase
79
6.7%
123
10.3%
0.62
0.46-0.85
0.002
No of cases 1186 1197
 
Table II. Numbers and rates of cases with ODFD. Separation of data according to mode of 
monitoring and phase of the trial.
Neonatal outcome
In the Swedish RCT (Amer-Wåhlin et al 2001), neonatal metabolic acidosis was 
defined as newborns with metabolic acidosis (cord sample or immediate neonatal 
sample) where the infant developed symptoms (neurological, cardio-respiratory, 
metabolic) requiring special neonatal care. The size of the trial allowed an assessment 
of outcome related to monitoring among the 351 babies that were admitted to the 
Special Care Baby Unit (SCBU).
In a follow-up study, the assessment of the clinical data was made by an 
experienced neonatologist who had no knowledge of which group of monitoring 
the case belonged to (Norén et al 2003). From the 351 cases, 29 were identified as 
having an adverse outcome related to labour and delivery. No difference between the 
two arms occurred during the first phase of the trial. Only when CTG+ST guidelines 
were followed more accurately with growing experience in the second phase of the 
trial, could a significant reduction in adverse outcome cases be noted from 1.0% 
(12/1197) to 0.17% (2/1186) in the CTG and CTG+ST arms, respectively.
The main aim of fetal surveillance is to minimise the risk of neonatal morbidity 
and mortality. The trial (Norén et al 2003) documented a significant reduction of 
moderate or severe neonatal encephalopathy in term newborns with a reduction from 
3.3‰ to 0.4‰ (OR 0.12, 95% CI 0.01–0.94, P<0.02).
There is a host of evidence to support the use ST waveform analysis as an adjunct 
to CTG monitoring from pre-clinical animal studies and RCTs. Nevertheless, there 
is still a need to explore the improvements in neonatal outcome in regular obstetric 
care as illustrated by the concept of phase IV studies. This aspect will be the focus 
of this thesis.
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Aims of the thesis
The overall aim of this thesis was to evaluate the ST waveform analysis of the 
fetal ECG as an adjunct to standard CTG as a new method for intrapartum monitoring 
and as part of regular obstetric care. More specifically:
To evaluate whether the addition of ST waveform analysis of the fetal  –
ECG will increase the ability to detect fetal intrapartum hypoxia and 
more appropriately intervene in cases of documented hypoxia and 
metabolic acidosis.
To analyse change occurring over time during the introduction of the  –
ST waveform analysis in regular care.
To test the hypothesis that CTG+ST clinical guidelines will identify  –
cases of intrapartum acidosis with accuracy similar to that of 
CTG+FBS. 
To undertake detailed analysis on the timing of CTG, FBS and ST  –
changes as part of a case control study of cord artery acidosis.
To investigate the usage of FBS in connection with CTG+ST  –
recordings.
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Material and methods
General aspects
All papers included in the thesis contain clinical data originating from labour 
wards across Europe and serve to provide information collected as part of the 
introduction of ST waveform analysis. The European Union ST analysis trial was 
a prospective multi-centre observational study funded by the European Union that 
involved ten European University hospitals studying the clinical implementation of 
ST analysis. Ethical approval and informed consent was obtained in those centres 
where ST analysis was not yet part of standard care.
The ‘City of Göteborg study’ (Paper I) was conducted as part of the European 
Union ST analysis trial between October 1 2000 and September 30 2002. This study 
contained data from 14687 term pregnancies in active labour. 
Detailed analysis of FBS, ST and FHR data (Papers III and IV) were conducted 
on a subset of 194 cases originating from the European Union ST analysis trial. 
This material included 6999 cases, all recorded in centres using FBS as an adjunct 
to standard CTG monitoring. An FBS was obtained in 911 cases of which all cases 
with cord artery pH <7.10 and corresponding controls were included in the analysis 
presented in Papers III and IV.
Paper III served as an observational study providing detailed analysis of cases 
with marked acidosis. In Paper IV, the analysis was extended into a case controlled 
study including cases with both acidaemia and acidosis. 
Additional to the ‘City of Göteborg study’ covering the total population of term 
deliveries in a University hospital setting, the outcome of two years of regular usage 
of CTG+ST analysis in a district hospital, was also audited (Paper II). These data 
include 3193 term deliveries from the city of Varberg, located on the west coast of 
Sweden.
In total 18791 term deliveries, defined as >36 completed gestational weeks, have 
contributed to the data analysis in this thesis, 7616 monitored with CTG+ST and 
11175 with CTG only.
STAN Fetal heart monitor
When FECG is recorded with a scalp and a skin electrode, changes in the T wave 
and the ST segment of the FECG are automatically identified and analysed by the 
application software.  The STAN system calculates an average ECG waveform from 
the FECG channel (scalp-to-skin lead). Every fetal heartbeat generates an FECG 
complex, which is assessed by the STAN monitor against strict quality criteria. 
The averaging is performed over 30 consecutively qualified FECG complexes. The 
device uses the average ECG waveform to process the T/QRS ratios, i.e. the ratio 
between the T-wave amplitude and the QRS-complex amplitude. A T/QRS baseline 
is computed every minute and monitored for multiple characteristics, contributing 
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to a determination of a T/QRS difference and the identification of a significant 
T/QRS change constituting an event (Table IV). The initial 20 T/QRS ratios are used 
to collect T/QRS baseline data to allow for an accurate determination of starting 
values used by the processing algorithms for event detection.
The analysis is displayed in the lower section of the STAN screen as a series of 
data points (T/QRS crosses) and event markers.  The ST analysis identifies patterns 
and changes in the T wave and ST segment over time, and displays events based 
on the analysis of those changes.  All events are stored in the event log. The user 
considers their interpretation of the standard CTG parameters together with the ST 
analysis results, and CTG+ST clinical guidelines help the labour ward staff to decide 
what action should be taken clinically in relation to CTG changes and ST events.
Figure 9. STAN recording showing a marked increase in beat-to-beat variation associated with a 
progressive baseline T/QRS rise (ST events) of 0.06 at 09:58 and 0.11 at 10:07, normal vaginal 
delivery at 11:19, Apgar scores 3-5, cord artery pH 6.97, BDecf 18.0 mmol/l. 
The STAN software conditions and analyses the raw FECG signal to identify 
characteristic parameters of the T wave and QRS complex used to calculate the T 
wave and QRS complex amplitudes and the T/QRS ratio. The decision algorithm 
evaluates these parameters looking for the three types of events:  (1) episodic T/QRS 
rise, (2) baseline T/QRS rise; and (3) biphasic ST.  The method defines biphasic ST 
as a condition where the slope of the ST segment has become negative, which the 
decision algorithm uses as an indicator of fetal abnormality. Biphasic events are 
further classified into category 1, 2, or 3 indicating that the slope is above baseline, 
crossing the baseline, or below baseline, respectively.
STAN recordings are automatically given a separate identification number at time 
of the recording. In the Varberg labour ward audit (Paper II), these unique case 
numbers were associated with patient ID numbers used in the hospital based patient 
database (Obstetrix, Siemens AB). Clinical data were obtained from the information 
collected as part of the Swedish National Perinatal Registry. Retrospective assessment 
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of STAN recordings of cases with ODFD and acidaemia (cord artery pH <7.05) were 
made to assess to what extent the clinical guidelines were followed and to calculate 
the response time (time from CTG+ST guideline indications to delivery). 
The CTG+ST clinical guidelines
CTG+ST clinical guidelines (Amer-Wåhlin et al 2007) provide detailed 
information on the definition of normal, intermediary, abnormal and preterminal 
FHR patterns (Table III). In case of an intermediary or abnormal CTG pattern, ST 
analysis was used as an adjunct to indicate when intervention is required (Table V). 
FBS was also used as an additional source of information both among CTG and 
STAN cases. 
Table III. CTG+ST clinical guidelines, classification of CTG.
The recommendation for using ST analysis is to start the recording at least 30 
minutes prior to onset of active pushing and to continue the recording until sufficient 
information has been obtained to expedite delivery. In case there are no indications to 
intervene, the recording should continue until delivery or at least within 20 minutes 
of delivery. In case of lack of ST data for more than four minutes, it is recommended 
that obstetric management be decided from the FHR information alone.
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Table IV. 
CTG+ST clinical guidelines, ST analysis.
Education and training
During the studies, labour ward personnel were systematically instructed and 
trained in (patho-) physiology of asphyxia and CTG and ST interpretation using 
educational material (Sundström et al 2000) and review of their own cases. 
Figure 10. Education and training material used in the EU study
Each ward had a part time midwife responsible for the education and data 
collection according to a protocol used throughout the European Union multi-
centre trial (Papers I, III and IV). Apart from the STAN recordings that were 
stored digitally, non-personalised clinical data was entered on a case record form, 
subsequently checked for consistency of data and entered into a standard database 
format.
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According to the protocol, all patients that entered the study would have the 
umbilical cord artery and vein acid-base status assessed at delivery. Cord artery and 
vein samples were obtained routinely using immediate cord clamping and acid base 
data were checked for accuracy according to A-V pCO2 difference of 1.0 kPa and 
pH ≥0.03 Units. Metabolic acidosis was defined as cord artery pH<7.05 and BDecf 
>12.0 mmol/l. BDecf was calculated using the Siggaard-Andersen ‘Acid Base Chart 
algorithm’ (Siggaard-Andersen 1971). 
In case of no cord acid-base data available, the case would still be counted for 
according to the criteria outlined in previous chapter ‘Assessment of acid base 
data’.
Specific aspects
STAN in clinical practice – The outcome of 2 year regular use in the city of 
Göteborg (Paper I)
The two labour wards located at Sahlgrenska University Hospital, Östra and 
Mölndal cover a population of 870 000. The two wards were equipped with eight 
STAN units in August – September 2000 after the educational process had been 
ongoing during the summer months. An additional three STAN units were installed 
during the last six months of the study. The two units are large labour wards with 
approximately 4000 deliveries per year each and 300 members of staff. Continuous 
fetal monitoring (conventional EFM) is the norm during second stage of labour. One 
of the labour wards participated in the Swedish RCT (Amer-Wåhlin et al 2001). 
The general indications for using ST analysis were 36 completed gestational 
weeks and situations where internal monitoring was the preferred method of fetal 
surveillance. Specific indication included high-risk pregnancies, women with 
suspicious or abnormal external CTG antenatally or in early labour, labour induction, 
oxytocin augmented labour and presence of meconium stained amniotic fluid. 
Additional use of ST analysis also became part of the training aspect. 
Clinical records at the two neonatal units were reviewed for cases of moderate/
severe neonatal encephalopathy (Low 1997) excluding cases with lethal malformations 
(one trisomia 13, two trisomia 18, two CNS malformations). Recordings originating 
from cases with adverse neonatal events or metabolic acidosis were reviewed and 
agreed upon by at least two of the authors. The assessment of tracings was performed 
without access to outcome data. Neonatal encephalopathy was defined as follows: 
minor, with irritability and jitteriness; moderate, with profound lethargy or abnormal 
tone; and severe, with coma or abnormal tone and seizures. 
STAN, a clinical audit: the outcome of 2 years of regular use in the city of 
Varberg, Sweden (Paper II)
The delivery ward at Varberg Hospital is a middle sized obstetric unit with 
approximately 1800 deliveries per year. The staff consists of approximately 40 
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midwives and 20 physicians are involved in fetal monitoring during labour. ST 
analysis was introduced at the hospital in April 2002 when two STAN units 
were acquired. In 2005, one additional unit was installed. The current analysis 
investigated the perinatal outcome over a two year period between January 1st 
2005 and December 31st 2006. Three midwives and two physicians were initially 
trained to become trainers of the rest of the staff. The training consisted of lectures, 
written information and multimedia based teaching. The ward had one physician 
and one midwife who were responsible for the continued education, data collection 
and case based discussions. The hospital does not have a neonatal care unit and 
risk pregnancies are referred elsewhere. This would include severe complications 
during pregnancy and/or intercurrent disease in mother and/or child when you 
could assume that the child needs neonatal care after delivery.
The general indications for using ST analysis were 36 completed gestational 
weeks and when a decision to use a scalp electrode for fetal surveillance was 
made. The specific indications for use of ST analysis were abnormal CTG pattern, 
meconium stained amniotic fluid, postmaturity, pre-eclampsia, diabetes, intra 
uterine growth retardation (IUGR) and twins. Because of the restricted number 
of STAN units, not all patients with CTG abnormalities could be monitored with 
CTG+ST analysis.
The CTG+ST clinical guidelines gave information on the definition of normal, 
intermediary, abnormal and preterminal CTG patterns. ST analysis was used when 
the CTG pattern was intermediary or abnormal. FBS was left at the discretion of 
the attending physician regardless of monitoring technique. 
Fetal scalp pH and ST analysis of the fetal ECG as an adjunct to CTG. A 
multi-center, observational study (Paper III)
The study was undertaken as part of the European Union ST analysis trial, an 
EU supported multi-centre project on intrapartum fetal monitoring. It involved the 
following obstetric units: Sahlgrenska University Hospital Göteborg, University 
Hospital Turku, Rikshospitalet Oslo University, Gentofte Hospital University 
of Copenhagen, Virchow Klinikum Charité Berlin, Hospital Eduard Herriot 
University of Lyon, Derby City General Hospital University of Nottingham, 
University Hospital of Perugia, University Hospital Utrecht and Derriford Hospital 
University of Plymouth under the coordination of Neoventa Medical, Mölndal.
ST analysis monitoring was used in high-risk pregnancies, women with 
suspicious or abnormal external CTG, induced or oxytocin-enhanced labour 
or meconium-stained amniotic fluid.  The decision to take FBS was left at the 
discretion of the clinician in charge and the time and pH reading was recorded. 
Cord artery metabolic acidosis was defined as a pH <7.05 in combination with a 
BDecf >12.0 mmol/l. Cord artery respiratory acidaemia was defined as cord artery 
pH <7.06 regardless of the BDecf.
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Fetal scalp pH and ST analysis of the fetal ECG as an adjunct to CTG to 
predict fetal acidosis in labour (Paper IV)
This study is an extension of Paper III where additional cases of moderate 
acidaemia are added together with a control group.
The marked acidosis group included all cases with cord artery pH <7.06 (53 
cases) and the moderate acidaemia group consisted of cord artery pH ranging from 
7.06 – 7.09 (44 cases).  Corresponding controls were identified from the database 
as the case recorded as the previous or next case, depending on which one was the 
closest, at the same site as the acidaemic case with a cord artery pH ≥7.20. 
Statistical analysis
The results were statistically evaluated with the Medcalc® statistical software 
(version 5, Medcalc, Mariakerke, Belgium). Student’s t-test or Mann-Whitney’s 
test was used for testing statistical significance for continuous variables. χ2 or 
Fisher’s exact tests was used for discrete variables and the odds ratios (OR) with 
95% confidence intervals (CI) was calculated. P-values < 0.05 were considered 
significant.
General study design
In the European Union ST analysis trial, the overriding project was aimed at 
investigating a method of dissemination of knowledge whereby academic units 
across Europe became regional Centres of Excellence (CoE). These CoEs would 
then provide quality assurance regarding ST analysis for education, training and 
certification. The initial task among these centres was to validate their own outcome 
and performance with the new methodology. 
Paper I constitutes the outcome over two years in the labour wards covering the 
total population of term deliveries in active labour in the city of Göteborg. These 
data represent the outcome from one of the CoE. The validation was subsequently 
extended to a district hospital audit covering two years of CTG+ST usage at the 
Varberg hospital (Paper II).
ST analysis of the FECG is intended as an adjunct to standard CTG interpretation. 
FBS with scalp pH analysis has served as an objective marker of intrapartum hypoxia. 
As part of the European Union trial, a large database was generated including close 
to 8000 digitalized EFM recordings with continuous FECG analysis, detailed notes 
on clinical performance and neonatal outcome. From these data the hypothesis 
that CTG+ST changes are as accurate as CTG+FBS data in detecting intrapartum 
hypoxia and acidaemia were tested. For this purpose, cases requiring FBS due to 
abnormal FHR and subsequently cord artery acidaemia at birth were identified and 
analysed. The aim of the study (Paper III) was to test the hypothesis that CTG+ST 
clinical guidelines identify cases of intrapartum acidosis with accuracy similar to 
that of CTG+FBS. 
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With the opportunity of improving standards of intrapartum care, detailed 
information on different patterns of events is required.  Thus, the analysis of the 
ST+FBS cohort of 911 cases was extended with the aim to analyse the sequence of 
CTG, FBS and ST changes as part of a case control study of cord artery acidosis 
(Paper IV).
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Results and Comments
Papers I and II 
CTG+ST usage rates
In the city of Göteborg (Paper I) during the two year period between October 
1st 2000 and September 30th 2002, 14687 deliveries entered active labour with a 
gestational age of more than 36 completed weeks. Of these, 4830 (32.9%) were 
monitored with CTG+ST analysis and a significant increase in usage was noted 
comparing year one to year two (28% versus 38%, p<0.001). For comparison, the 
CTG+ST usage rate in the Varberg audit was 59% after two years. Although there 
were clinical indications for the use of ST analysis, the majority of cases had ST 
analysis undertaken on the basis of midwifes decision and the need for more accurate 
information.  
Interventions for fetal distress
Table V provides a summary of operative intervention rates in Paper I and II.
Total operative deliveries for 
fetal distress (ODFD)
CS for fetal distress VE/Forceps for fetal 
distress
City of Göteborg study
Year No of 
cases
Monitored 
CTG+ST
CTG+ 
STa 
CTG Total CTG+ 
STa 
CTG Total CTG+
STa 
CTG Total
1 7325 2057 
(28.1%)
11.1% 4.8% 6.6% 5.2% 2.5% 3.2% 5.9% 2.3% 3.3%
2 7362 2773 
(37.7%)
10.3% 3.6%* 6.1% 5.1% 1.9% 3.1% 5.2% 1.7% 3.0%
Varberg audit
2 
years
3193 1871
(59%)
6.8% 6.7% 6.7% 3.1% 4.2% 3.5% 3.7% 2.5% 3.2%
 
Table V. Operative delivery rates. a Cases with perceived risk and need for close surveillance with 
CTG + ST available. * = p<0.05
Both cohorts cover all women in active labour at term. The total ODFD rates 
were the same in the different populations. Although, the group monitored with 
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conventional CTG should be at low risk with less operative deliveries as found 
in the Göteborg data, in Varberg the total CS rate was significantly reduced in the 
CTG+ST group. Among the acute CS for ODFD in Varberg, emergency (crash) CS 
were also significantly reduced from 1.51% (19 cases) to 0.27% (5 cases) in the 
CTG and CTG+ST monitored groups respectively (OR 0.18, 95% CI 0.07-0.49). 
Of the five crash CS cases monitored with CTG+ST, four had CTG+ST indications 
to intervene. None of the 24 cases had metabolic acidosis and only one had Apgar 
below seven at five minutes (CTG monitored case). Thus, it appears that lack of 
continuous information about fetal myocardial reaction causes increased uncertainty 
in the timing of intervention resulting in more emergency procedures. The rates of 
operative deliveries for reasons not including fetal distress were 8.0% (year 1) and 
8.6% (year 2), the corresponding figure for the Varberg audit was 9.0%.
In fetal monitoring, it is important not only to decide when to intervene but 
also to avoid an intervention when not indicated. Apart from analysing the rate of 
interventions, the relationship between indications to intervene, mode of intervention 
and outcome were assessed. Table VI gives the details from the Varberg audit when a 
decision to intervene operatively for fetal distress was made. The extent to which the 
clinical guidelines had indicated a need to intervene was made retrospectively and 
without knowledge of outcome.
Operative deliveries for 
fetal distress
Number of 
cases / % of all 
deliveries
Cord artery pH 
(mean, 95% CI)
Comments
CS for fetal distress
According to
CTG+ST guidelines
32/1.8 7.19
(7.14-7.23)
Outside 
CTG+ST guidelines
26/1.3 7.26**
(7.23-7.28)
3 cases had a normal CTG and ST events, 
2 cases had normal CTG+ST and 
21 cases had CTG changes with normal ST.  
Lowest cord art pH 7.12, all had Apgar ≥7 at 5’
Vag op deliv for fetal 
distress
According to
CTG+ST guidelines
41/2.2 7.14
(7.11-7.17)
Outside 
CTG+ST guidelines
28/1.5 7.19*
(7.16-7.22)
2 cases had normal CTG+ST, 
26 cases had CTG changes with normal ST. All cases had Apgar 
9-10 at 5’, 4 cases had respiratory acidaemia (pH 7.06 – 7.09).
Table VI. ODFD according to/and outside CTG+ST clinical guidelines from Varberg database. * = 
p<0.05. ** = p<0.01, unpaired T-test
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Cord artery pH data show significant differences related to the extent to which 
the CTG+ST clinical guidelines were followed or not. Those cases delivered with 
CS for fetal distress outside the guidelines had the same cord artery pH as those 
delivered by CS for FTP (pH 7.27; 7.25-7.29, p=0.50). The same observation was 
made with regard to vaginal operative deliveries with FTP cases showing cord artery 
pH 7.19; (7.17 – 7.21, p=0.92). It may also be noted that of the 58 cases with CS, five 
were intervened upon despite a normal CTG according to the retrospective analysis. 
In three of these, ST events were recorded in connection with the intervention, 
corresponding to 0.16% of those monitored with ST analysis. 
Of all ODFD (127 cases), 47 cases (21 CS and 26 VE), corresponding to 2.5% 
of all deliveries, had an operative intervention outside of the guidelines because the 
CTG pattern was considered abnormal to the extent that an operative delivery was 
perceived to be required. This is most likely the outcome measure that will be the 
most markedly affected by increasing user experience and trust in the new method. 
In a recently conducted US study of initial exposure to ST analysis the corresponding 
figure was significantly higher 5.3% (28/530) (OR 0.46; 95% CI 0.27-0.75) (Devoe 
et al 2006),
Validated cord artery metabolic acidosis
The increased use of ST analysis in the ‘City of Göteborg’ (GOT) study was 
associated with a significant reduction in cord artery metabolic acidosis rates in 
the group monitored with CTG+ST as well as in the total population, OR and 95% 
CI; 0.49, 0.25-0.98 and 0.58, 0.37-0.93, respectively. No further improvement in 
metabolic acidosis rate was noted as ST analysis usage increased from 38% (GOT 
second year) to 59% (Varberg).
Cases with cord acid base data Cord artery metabolic acidosis rates
GOT study CTG+STa CTG CTG+STa CTG Total
Year 1 1868/2057
90.8%
4721/5268 89.6% 21/1868 1.12% 29/4721 
0.61%
50/6589 
0.76%
Year 2 2503/2773
90.3%
4083/4589 89.0% 14/2503 0.56%* 15/4083 
0.37%
29/6586 
0.44%*
Varberg audit
2 years 1776/1871
94.9%
1222/1322
92.4%
8/1776
0.45%
7/1222
0.57%
15/2998
0.50%
Table VII. Fetal outcome. a Cases with perceived risk and need for close surveillance. *= p<0.05.
CTG+ST clinical guidelines include recommendations on the response time. 
During the first year there were 21 cases born in Göteborg with cord artery metabolic 
acidosis. Out of these, 14 had ST events recorded in combination with CTG changes 
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and occurring more than17 minutes before delivery in second stage and more than 
25 minutes in first stage of labour indicating a prolonged response time. This gives 
an incidence of 0.75% (14/1868) of cases with a prolonged response time. 
During the second year, 14 metabolic acidosis cases were recorded. The number 
of cases with a prolonged response time was significantly reduced during the second 
year to 0.28% (7/2503), (OR 0.37, 0.15-0.92). The corresponding rate of cases with 
a prolonged response time in Varberg was 0.17% (3/1776).
A summary of CTG and ST changes, mode of delivery and neonatal outcome is 
given in Table VIII. Of the 41 cord artery metabolic acidosis cases with CTG+ST 
data available, ten did not present abnormalities according to CTG+ST clinical 
guidelines, eight of these showed intermediary/normal CTG patterns and all ten 
cases had uncomplicated neonatal periods. 
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Table VIII. Summary of CTG and ST changes, mode of delivery and neonatal outcome. a  - 35 cases, 
one case had STAN disconnected for 1h 16 min prior to delivery and EFM data could not be assessed, 
and one case with no ST data last 28 min. b – Complications included sepsis (1 case), meconium 
aspiration/respiratory distress (2 cases), HIE, gr II (2 cases). c – Eight cases, all with CTG+ST data 
available but one case starting during second stage and not following CTG+ST clinical guidelines. 
d – Two cases with meconium aspiration and two cases with HIE, gr II and III. 
These data indicate that a CTG+ST guidelines indication to intervene occurred in 
83% (33/40) of the cases where CTG+ST data was available and the recording started 
according to recommendation prior to active pushing, i.e. adequately recorded cases. 
The dominant fetal pattern of reaction in connection with metabolic acidosis was an 
ST rise occurring in connection with an abnormal CTG pattern during second stage. 
It may also be noted that 78% of the cases with cord artery metabolic acidosis had 
an uneventful neonatal course. 
Moderate and severe neonatal encephalopathy monitored by CTG+ST
Table IX provides a summary of all cases with HIE diagnosis defined as acidosis 
at time of delivery, low Apgar scores at five minutes, need for resuscitation and 
abnormal neurological findings. 
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GOT 1 Abn
2nd 
stage
6.97 6.69 18.0 - Base-
line 
rise  
0.11
79 SVD 3/5 Mec aspir. seizures 
at 12h. abn EEG. 
multi organ symp-
toms. 20d in NICU. 
HIE gr II
GOT 2 Abn
2nd 
stage
6.94 9.3 15.3 - Base-
line 
rise 
0.06
44 SVD 4/5 Normal cardiopulm 
adaptation. hyper-
tonus and seizures 
during 24h. abn 
EEG. normal CT. 
HIE II
V-berg 1 Abn
1st 
stage
- - - 7.23 
and 
7.17
Base-
line 
rise 
0.06
46 Compli-
cated C/S
0/0 Multiorgan 
symptoms, HIE III, 
parasagital infarcts 
on MRI
V-berg 2 Abn
2nd 
stage
7.01 8.75 12.9 Base-
line 
rise 
0.06
27 Compli-
cated
VE
3/5 HIE II, parasagital 
bleedings + capsula 
interna ischaemia 
on MRI
Table IX. Summary of all HIE cases in Paper I and II.
The overall incidence of HIE gr II and III was 0.65 ‰ (4/6147). Although the cases 
are few, relevant information may still be obtained by analyzing the reason for the 
delay in delivering these fetuses and the CTG pattern in particular associated with the 
ST events. Figure 11 provides a snapshot of the part of the tracings where the initial 
significant ST event occurred. From these data it appears as if the dominant pattern 
associated with an ST rise was unstable FHR with marked variations, including beat-
to-beat.
Such patterns may previously have been regarded as erroneous due to miss 
triggering but this is no longer the case with the availability of modern digital signal 
processing.
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GOT HIE case 1
 
          GOT HIE case 2
        
      Varberg HIE case 1
        
 
   
  Varberg HIE case 2
Figure 11. Samples of CTG+ST sequences obtained at time of ST event in the four cases with HIE gr 
II and III
Summary of the clinical outcome data
It can always be argued that a clinical trial provides special focus on the issues 
studied. Thus, it should be interesting to further document the introduction of a new 
technology as was done with the current study originating from busy labour wards 
with a large number of caregivers. 
Paper I contained a population based prospective study covering the total number 
of deliveries in the city of Göteborg, over two years. During the second year of the 
study period, metabolic acidosis rates were below what was seen in the CTG+ST 
group of the Swedish RCT (Amer-Wåhlin et al 2001), 0.56% and 0.69% respectively. 
The rate noted in the CTG+ST group during the second year was similar to that 
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recorded after retraining in the Swedish RCT (0.52%). 
The reduction in cases with cord artery metabolic acidosis noted within the two 
years could be related to two major findings: (1) the increase in use of ST analysis 
and (2) the improved response time to ST events associated with significant CTG 
changes.
The response time is dependent on the ability of the staff to assess the data in a 
uniform fashion. The hypothesis that the addition of ST analysis to standard FHR 
tracing analysis would improve the consistency and accuracy of clinical decision 
making has been tested by Ross et al 2004. Using the outcome of observer agreement 
for need and timing of intervention, experienced users showed more consistent and 
accurate assessment of data as ST analysis was added as compared to standard FHR 
analysis.
The implication of the findings of the Swedish RCT (Amer-Wåhlin et al 2001) 
was that the majority of cases with an adverse outcome of labour had no antenatally 
known risk factor. Thus CTG+ST should have a role to play also in a low risk 
environment such as in a general district hospital. The Varberg audit (Paper II) 
provides data which are coherent with what was noted in both the CTG+ST arm of 
the Swedish RCT and the ‘City of Göteborg’ study second year outcome
Papers III and IV
ST analysis and FBS as adjuncts to CTG
ST analysis serves as an adjunct to standard CTG similar to what has been the case 
with FBS. The issue evaluated in these studies is to what extent these two additional 
parameters complement each other.
In the large European Union ST analysis trial database of 7823 deliveries, 6999 
deliveries where recorded in centres using FBS (Paper III). FBS was performed in 
13% (911/6999) of the cases. In 53 cases, marked cord artery acidosis (pH <7.06) 
was found and 44 cases showed moderate cord artery acidaemia (pH 7.06-7.09) at 
birth. Comparisons were made with 97 control cases (pH ≥7.20) (Paper IV). Apart 
from one perinatal death (e-coli septicaemia) no adverse neurological findings were 
noted during the neonatal period among the 194 cases. Table I provides baseline 
characteristics of the different groups.
SCBU admission was associated with low Apgar scores (<7 at 5 minutes) in 15 
of the 26 cases (58%) with marked acidaemia and four of the 14 (26%) cases with 
moderate acidaemia. The corresponding rate for the control groups was one out of 12 
(8%). No relationship between antenatal risk factors and degree of cord acidaemia 
and acidosis could be noted.
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Indications to intervene
Metabolic acidosis group
Of the 20 cases with metabolic acidosis, 19 had adequate ST analysis information. 
One case with adequate data of the total group of 20 cases was not identified by 
CTG+ST giving a sensitivity of 95%. Figure 12 shows the STAN recording of this 
case. All five fetuses with Apgar scores below six at five minutes were identified by 
CTG+ST changes. All 12 cases with FBS data obtained within one hour of delivery 
and in connection with metabolic acidosis showed acidaemia with the highest pH 
of 7.16, giving a sensitivity of 100%. Kappa statistics for comparisons between pH 
<7.15 obtained within the last hour of labour and ST events showed a Kappa value 
of 0.63, indicating a moderate level of agreement (Sim and Wright 2005). 
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Marked acidosis group, 
n = 53
26 75 66*** 5*** 8*** 7.01 9.80 11.1 49%***
Control group 1, 
n = 53
26 74 28 9 10 7.25 6.61 4.1 15%
Moderate acidaemia 
group, n= 44
16 77 55*** 7*** 9*** 7.08 9.04 9.11 32%*
Control group 2, 
n = 44
18 70 18 9 10 7.25 6.75 3.4 11%
Table X. Baseline characteristics of the groups. Antenatal risk factors included: >42 gestational 
weeks, oligohydramnios, pre-eclampsia, hypertension, diabetes mellitus, premature rupture of 
membranes and growth retardation. ***; p<0.001, unpaired t-test or Chi2 .
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Figure 12. STAN recording obtained during second stage of labour ending eight minutes before the baby 
was delivered by an outlet VE. FBS pH 7.16 obtained at onset of recording. Apgar scores 7-9-10 at 1, 5 
and 10 minutes. Cord artery pH 7.03, pCO2 8.53 kPa, BDecf 12.3 mmol/l, normal neonatal period.
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Total no of cases/
no of SCBU admis-
sions
Intervention according to CTG+ST 
guidelines; no of cases; median and 
range of time between indication to 
intervene and delivery, minutes
Intervention according to 
FBS <7.20;
no of cases, median scalp 
pH and range
Cord metabolic acido-
sis and Apgar scores 
<6 at 5’
5/5 5 cases
34 (26–103) minutes
4 cases
pH 6.97 (6.92–7.14)
Cord metabolic acido-
sis and Apgar scores 
>5 at 5’
15/10 13 cases
25 (2–46) minutes
8 cases
pH 7.07 (6.94-7.16)
 
Table XI. Summary of the data available in the metabolic acidosis group.
One aspect to consider is the lag time between indications to intervene, according 
to CTG+ST guidelines, and delivery in the metabolic acidosis cases and the potential 
delay in case FBS was obtained. Among the 20 cases with metabolic acidosis, eleven 
had FBS obtained after the guidelines had identified abnormality. In eight of these cases 
a progressive rise in T/QRS baseline occurred. Figure 13 gives the relationship between 
the lag time (time between last ST event and FBS) and scalp pH in these eight cases. 
 
Figure 13. A plot of the relationship between the number of minutes that elapsed from a ST event 
of a baseline T/QRS rise to FBS and the calculated hydrogen ion concentration [H+]. The linear 
regression line is included together with the corresponding correlation coefficient and p-value.
60
70
80
90
100
110
120
130
3 3 5 10 12 14 15 23
Time between last baseline T/QRS rise and FBS, minutes
[H
+]
 m
m
ol
/L
r = 0.88, p = 0.004
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The delay issue in responding to information can be illustrated by the finding 
that of the 15 cases with metabolic acidosis requiring SCBU, all 14 cases adequately 
monitored on CTG+ST had indications to intervene for 19 minutes or more prior to 
delivery. Figure 14 illustrates such a case of progressive T/QRS rise in second stage 
of labour where the FHR pattern may not look that ominous. FBS was obtained at 
04:22 (pH 7.06) and an operative vaginal delivery occurred 20 minutes later giving a 
lag time from the ST event indication to intervene to delivery of 36 minutes. Similar 
FHR patterns was seen in the above described HIE cases.
Figure 14. Recording obtained during second stage of labour in a para 0 with pre-eclampsia, outlet 
VE delivery at 04:42, Apgar scores 2-7-8, cord artery pH 6.97, pCO2 8.40 kPa, BDecf 15.3 mmol/l. An 
FBS was obtained at 04:22 (arrow), pH 7.06. The baby was admitted to SCBU, recovered initially but 
collapsed at 2h and died from e-coli septicaemia.
Of the 53 cases with marked cord acidosis, 22 cases had an FBS obtained after the 
ST event thus adding to the response time. The median time between the significant 
ST event and FBS was 14 minutes (range 8-25, 95th CI). One of these cases is 
illustrated in Figure 15.
Figure 15. Para 1, spontaneous onset of delivery after 39 weeks. Indications to intervene 
at 11:59. Two FBS (pH 6.92 and 6.93) at 12:20 and 12:22. CS for fetal distress at 12:39. 
Apgar 1 at 1min. ,4 at 5 min., cord art pH 6.93, BDecf 12.4 mmol/l. Uneventful observation 
in special care.
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Identification of acidosis and non-acidosis situations
The extent to which adverse situations will have an impact of cord artery pH 
is a function of time. Figure 16 shows the distribution of cases in relation to time 
between the CTG+ST indications to intervene and time of delivery. The graph 
indicates the proportion of cases within a certain acidosis/control group that start 
showing CTG+ST abnormality in relation to time to delivery. In the control group, 
57% (17/30) of the events occurred within 16 minutes of delivery as compared to 
16% (11/67) in the combined acidosis group (OR 6.66, 2.29 – 19.86, p <0.001). Of 
the remaining 13 cases (43%) in the control group, two cases displayed biphasic ST 
(followed by normal FBS), two showed persistent CTG+ST changes (one normal 
FBS) and nine had episodes of decelerations plus increased T/QRS ratio in first stage 
of labour, emerging more then one hour prior to delivery in seven cases. Among the 
nine cases, two had abnormal FBS, pH 7.09 and 7.14 obtained within ten and 12 
minutes of the CTG+ST event respectively.
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Figure 16. The figure illustrates the occurrence of CTG+ST clinical guideline indications of need 
to intervene in relation to minutes remaining until delivery. Cases are grouped according to level 
of cord artery pH (marked acidosis; pH < 7.06, moderate acidaemia; pH 7.06 – 7.09, controls; pH 
≥7.20.) CTG+ST changes are significantly more frequent as compared to controls 45 minutes (marked 
acidosis) and 20 minutes (moderate acidaemia) before delivery (*p<0.05, ** p<0.01, *** p<0.001, 
Chi2 –test).
The time factor, i.e. the time between onset of significant ST events and delivery 
can be illustrated by the observation that of those with CTG+ST events recorded 
within 16 minutes of delivery, 61% had cord artery pH ≥7.20. The corresponding 
figure for cases where CTG+ST indications occurred more than 16 minutes before 
delivery was 19% (OR 6.66, 2.29 – 19.86, p<0.001). Thus, the most common scenario 
would be the onset of myocardial anaerobic metabolism, as identified by an increase 
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in T/QRS, occurring at a fetal pH of >7.20. This observation is supported by pH 
<7.20 occurring on average 14 minutes after a significant CTG+ST event in cases 
with marked acidosis. The corresponding figure in cases with CTG changes at start 
of a ST analysis recording was 29 minutes (Paper IV).
Abnormal FHR, ST analysis and FBS
Out of the 194 cases included in the study, 121 had abnormal CTG patterns, 94% 
(50/53); 77% (34/44) and 38% (37/97) of the cases were obtained from marked 
acidosis, moderate acidaemia and controls, respectively.
Of the 121 cases with an abnormal CTG, 84 (69%) showed a cord artery pH of 
<7.10. ST waveform changes indicated a need for intervention in 83% (70/84) of 
these. Of the seven cases with abnormal FBS and normal CTG+ST, six had respiratory 
acidosis with normal neonatal period and one case had normal cord artery pH (≥ 
7.20). All these seven cases had the low scalp pH obtained during second stage.
Of the 12 cases with abnormal CTG+ST changes but normal FBS, five developed 
acidosis subsequently and seven had a normal cord acid base. 
Comments
Although ST and scalp pH are equally capable in identifying cases with 
intrapartum asphyxia (metabolic acidosis and low Apgar), with ST changes emerging 
on average 14 minutes prior to an abnormal scalp pH, some discrepancy is noted 
in cases of respiratory acidaemia developing in second stage of labour. Obviously, 
the significance of identifying those cases can be discussed. More relevant is what 
information is obtained in first stage when CTG is indicating abnormality and 
ST+FBS is normal. In such situations continuous information is essential in case 
of perinatal asphyxia developing. The patterns recorded among the 61 cases that 
showed CTG changes at onset were examined to analyse if FBS added value in those 
cases
Cases with CTG changes at start of ST analysis
Table XII summarises the relationship between ST findings recorded prior to FBS 
in cases with CTG changes at onset.
CTG+ST guidelines indicated abnormality prior to an abnormal FBS in 14 out 
of 17 cases. In all of theses cases CTG changes were noted already at onset of the 
recording. The median duration between CTG+ST indications to intervene and 
an abnormal FBS was 29 minutes (range 11-74, 95% CI). Of the three cases not 
identified by CTG+ST, two had a late onset of the recording in second stage and 
the third had an FBS obtained nine minutes before a spontaneous vaginal delivery 
in connection with bradycardia and uterine rupture (cord artery pH 6.97, pCO2 15.0 
kPa, BDecf 5.0 mmol/l, normal neonatal period).
Furthermore, of those 14 cases in the marked acidosis group that showed a normal 
ST+FBS initially, 11 (79%) subsequently developed ST changes and those that did 
not show ST changes had their recordings disconnected for more than 25 minutes 
prior to delivery. In the moderate acidosis group only two cases showed ST changes 
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after an initially normal ST+FBS sequence.
The data does not support the need for an FBS in case of CTG changes at onset 
of the CTG+ST recording. However, as previously stated, if there is evidence of an 
unstable fetal condition, an FBS is required in case a decision is made to continue 
labour. The alternative is to decide to intervene and deliver based on the fact that 
there is sufficient information to identify inadequate fetal response and inability to 
maintain steady-state.
Intervention caused by overreacting to CTG or CTG+ST data may constitute a 
problem. Although, the RCTs (Westgate et al 1993, Amer-Wåhlin et al 2001) showed 
fewer interventions for fetal distress with CTG+ST, this may be an issue worthy 
some further documentation. The Varberg audit (Paper II) provided an opportunity 
to study the clinical application of CTG+ST clinical guidelines. From these data 
(Table VI) it appeared that when action was done on the basis of an intermediary/
abnormal CTG pattern only, the cord-acid base was identical to the situation where 
intervention was done for FTP. One other aspect to consider is the extent to which 
an ST event may cause an intervention despite a normal CTG. Of the 58 cases with 
CS in the Varberg study, five were intervened upon despite a normal CTG in the 
retrospective analysis. In three of these, ST events were recorded in connection with 
the intervention, corresponding to 0.16% of those monitored with CTG+ST.
Cases with CTG 
changes at onset – 
61/194 cases
Normal FBS Abnormal FBS
CTG+ST findings 
recorded prior to FBS
Normal 
CTG+ST
Abnormal 
CTG+ST
Normal CTG+ST Abnormal 
CTG+ST
Marked Acidosis 
group, n = 21/53
14 0 2 (One inadequate recording started in 2nd 
stage and one case had a uterine rupture in 
connection with a normal vaginal delivery)
5
Moderate Acidaemia 
group, n = 16/44 
6 1 1 (Inadequate recording started in 2nd stage) 8
Controls, n = 24/97 23 0 0 1
Total 43 1 3 14
Table XII. Relationship between FBS and CTG+ST guideline indications of abnormality in cases with 
CTG changes (intermediary or abnormal) noted at start of ST analysis.
50
General discussion
The expectation of society is that the application of the results of health 
technology assessment should improve quality of care and to ensure that available 
resources are used effectively. The aim of the European Union ST analysis trial was 
to develop and validate a model whereby the user aspects are put to the fore to 
stimulate postgraduate training and an appropriate management structure. The data 
from this trial, presented as part of this thesis, has provided detailed information on 
the outcome when ST analysis was introduced clinically as an adjunct to standard 
CTG for fetal surveillance in term pregnancies. 
Quality improvement research
The introduction of a new medical methodology requires RCTs to provide 
efficiency data comparing conventional methodology with the new. Apart from 
RCTs, quality improvement (QI) research may also be undertaken. QI is intended to 
result in improvements in care for an entire population of patients. Unlike RCTs, QI 
does not assign patients to different therapies or care practices, or require the testing 
of a hypothesis. Nevertheless, when QI is employed in a prospective manner, it can 
become as powerful as RCTs, and can be generalized to a similar extent (Ringer 
2008).
Metabolic acidosis and HIE
The first aim of the present thesis was to demonstrate that the outcome of the 
Swedish RCT (Amer-Wåhlin et al 2001) could be verified in clinical praxis. In a 
cohort of 17880 term deliveries in active labour (Papers I and II), it was shown 
that the metabolic acidosis rate after the first year of CTG+ST usage was 0.51%. 
This is identical to the rate noted among CTG+ST cases in the Swedish RCT during 
the second phase of the study, when the staff had become accustomed to the new 
method. 
This ability to maintain a low risk of metabolic acidosis also had an impact on 
the total metabolic acidosis rate (0.46%). The overall incidence of HIE gr II and III 
was 0.65 ‰ (4/6147). The four cases all showed a delay in responding (27, 44, 79 
minutes in second stage and 46 minutes in first stage, respectively) adding to the 
significance of the CTG+ST method despite the rarity of significant HIE. Although 
these are rare cases, they are in focus when assessing fetal surveillance methods. 
There is now conclusive evidence that CTG+ST clinical guidelines will significantly 
decrease the risk of neonatal encephalopathy (RR 0.33; 95% CI 0.11-0.95) (Neilson 
2006). 
The FDA required American data before accepting the European research and 
experience (FDA 2005).  This allowed for the new ST analysis method to be validated 
further and data was presented on the continuity of assessing CTG+ST information 
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both at bed-side and by experts (Devoe et al 2006).
The European Union trial involved ten academic centres across Europe some 
of which has published their own reports on CTG+ST. The Utrecht group was the 
first to summarise their findings (Kwee et al 2004), with 449 recordings available 
for analysis of outcome in relation to ST changes. Eighteen (4.0%) neonates were 
born with metabolic acidosis. Significant ST changes (18-31 min before birth) were 
present in all five cases with pH>7.00. The report concluded that CTG+ST analysis 
was more specific in detecting fetal acidaemia than CTG alone. One may comment 
that the high metabolic acidosis rate may partly be due to late cord clamping with 
falsely low pCO2 reading.
More recently, the group from Lyon presented their data (Massoud et al 2007) 
from 1889 CTG+ST recordings. The metabolic acidosis rate was 0.38% with no 
adverse outcome and no false negative CTG+ST cases among the seven with 
metabolic acidosis. Their data also showed that over time with training and experience 
the adherence to the guidelines improved significantly as did the accuracy of the 
interpretation of the FHR. 
The importance of meeting with the basic requirements of CTG assessment was 
highlighted in the report from St George’s Hospital, UK (Doria et al 2007). Their 
data are rather disappointing in that no improvement was noted among the 1500 
first cases monitored with CTG+ST. However, the reason identified by retrospective 
case based analysis was that CTG+ST guidelines were not followed and acted upon. 
The study identified the need for more intensive training and assessment of the users 
regarding the use of the CTG+ST analysis. Perhaps the outcome is a reflection of 
the British Royal College of Obstetrics and Gynaecology recommendation to use 
intrapartum EFM only in defined high-risk situations (RCOG 2001).
FBS and ST analysis as adjunct information to the CTG
Fetal surveillance is all about identifying when there is a risk of a fetus to be 
exposed to hypoxic stress beyond its capacity to respond. Basically, the FHR tracing 
depends on numerous factors. As a consequence, additional information is required 
to pin-point the situation when the fetus is no longer able to fully compensate. 
The physiology of acidosis and ST events
A T/QRS rise in the FECG reflects myocardial anaerobic metabolism whereas 
a lowered pH in the blood (scalp-pH or cord blood pH) is largely a function of 
the free hydrogen ions (H+) generated by the accumulation of CO2 (Figure 2) and 
the respiratory component of fetal acidosis will always dominate. This means that 
ST events may occur at a wide range of pH values but the more pronounced the 
drop in pH is, the more likely it is that it also contains a metabolic component. 
However, there will be situations where the pH may drop even below 7.0 without the 
myocardial anaerobic metabolism contributing to the accumulation of free hydrogen 
ions. Obviously, these are rare situations that need to be recognised by adequate cord 
acid base analysis and the calculation of BDecf.However, the common pattern is for 
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ST events to occur when pH has dropped below 7.20 and before it reaches 7.10. 
As shown in Paper II, on average, the cord artery pH will drop to 7.19 (95th CI 
7.14-7.23) when a CS is undertaken because of CTG+ST indications. In case of 
intermediary/abnormal CTG but no ST changes the corresponding pH is 7.26 (7.23-
7.28). Thus the addition of an ST event will indicate a drop in cord artery pH by 0.07 
units, and it may be speculated that this drop could be caused by the contribution of 
anaerobic metabolism. Furthermore, the CTG+ST events occurred prior to the cord 
blood being available and one would therefor assume a somewhat higher pH at onset 
of ST changes.
FBS has been the point of reference ever since CTG was introduced, although the 
effectiveness of the method in clinical practice has been questioned. In the Plymouth 
RCT (Westgate et al 1993), despite the use of a strict protocol, 39% of cases had FBS 
performed unnecessarily, and 33% of cases did not have it performed when it was 
indicated. The decision to obtain an FBS depends on the interpretation of the CTG. 
If the level of CTG interpretation is suboptimal, the value by monitoring with FBS is 
limited (Greene et al 1999). 
In the Swedish RCT (Amer-Wåhlin et al 2001) the use of FBS in the two arms 
was 10.7% and 9.3%, respectively. In a trial from Dublin (Impey et al 2003) it was 
shown that as a result of admission test the use of continuous CTG and FBS increased 
(CTG from 42% to 58%, FBS from 8% to 11%) without signs of improved neonatal 
outcome.
In summary, FBS can be used along with CTG monitoring to assess fetal acid-base 
status during labour and can reduce operative intervention but it requires additional 
expertise, is time consuming and gives only intermittent information (Whebble et al 
1989).
ST analysis and FBS – availability of information
Scalp lactate has recently been introduced as an option to more easily obtain a 
biochemical marker of ongoing hypoxia (Kruger et al 1999, Wiberg-Itzel et al 2008). 
In a recently published multi-centre RCT from Sweden, lactate and pH as adjunct to 
CTG were compared (Wiberg-Itzel et al 2008). It was not demonstrate that lactate 
was superior to pH, considering outcome markers such as ODFD or cord metabolic 
acidosis, although the success rate in lactate sampling was higher.
In the Swedish RCT on ST analysis as an adjunct to CTG (Amer-Wåhlin et al 2001) 
there was a significant reduction in metabolic acidosis and ODFD in the CTG+ST 
group. The question is how these parameters, FBS and ST serving as adjuncts to the 
CTG, interrelate. 
Data from the Plymouth RCT (Westgate et al 1993) showed that it may be difficult 
to use FBS correctly. In the Swedish RCT (Amer-Wåhlin et al 2001), 496 cases out 
of 4966 monitored with both CTG and CTG+ST had a FBS. In the retrospective 
analysis, the ST information was made available also in the group monitored with 
CTG only. 
The purpose of the FBS that were performed was to identify hypoxia and acidosis. 
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However, of the total number of metabolic acidosis cases in the trial (46 cases) FBS 
was obtained in only six cases. Of these six, five cases had CTG+ST indications 
to intervene and one case had no ST data available for retrospective analysis. FBS 
results were abnormal in only one case (pH 7.13).
The difficulty to use FBS correctly also emerged in the European Community 
(Luzietti et al 1999) and the Nordic observational study (Amer-Wåhlin et al 2002). 
In these studies of 894 (320+574) cases, FBS was performed in 78 cases (8.7%). In 
the cases with FBS, the CTG pattern appeared normal in 47%, intermediary in 31% 
and abnormal in 22%. Of the 78 cases, only six had a scalp pH <7.20. All of these 
cases had ongoing ST changes. 
In the European Union trial database (Paper III) 20 cases had metabolic acidosis, 
19 with adequate CTG+ST information and 11 had an FBS obtained after CTG+ST 
guidelines had identified abnormality. 
Another important observation was that of those 14 cases (Paper IV) in the 
marked acidosis group (cord artery pH <7.06) that showed a normal CTG+ST and 
a normal FBS, 11 (79%) subsequently developed ST changes and those that did not 
show ST changes had their recordings disconnected for more than 25 minutes prior 
to delivery. Thus, continuity of information is one of the most important aspect of 
fetal intrapartum surveillance. 
FBS may risk a delay in delivering
CTG+ST clinical guidelines provide recommendations on the timing of delivery 
after significant events have been recorded. Whatever is causing a delay may be 
regarded as a threat to intact survival. Therefore it is essential to respond quickly 
when there is sufficient information, and in particular during second stage with 
active pushing.
In the studies, one of the reasons for a delay in responding was the decision to 
take an FBS as illustrated by the case presented in Figure 17. 
Despite clear indications by emerging CTG changes and progressive rise in T/
QRS a decision was made to undertake an FBS which was 6.93. The baby was 
born one hour after the onset of the hypoxia process in second stage of labour. The 
importance of recognising the time factor became evident as the 0.01 pH unit fall per 
minute became clear (Paper IV).
With the use of CTG+ST clinical guidelines, significant hypoxic event can be 
indicated. The current set of data shows the impact of time. Considering that an FBS 
was obtained in median14 minutes (range 8-25, 95th CI) after the ST event in 22 out 
of the 53 cases with marked acidosis it seems appropriate to try to reduce the FBS 
delay factor as much as possible.
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Figure 17. 31-year old para 1, normal pregnancy, induction at 40+1 after 3 days preterm rupture of 
membranes. Emergency CS for threatening asphyxia at 04:48 after an attempted complicated VE. 
FBS at 04:21: pH 6.93. Female, BW 3200, Apgar 1-1-3, Cord sample (vein): pH 7.03, pCO2 7.4 kPa, 
BDecf 14.6 mmol/l. Neonatal resuscitation, on respirator for first 36 hrs. No signs of seizures, normal 
electroencephalogram.
 
Thus, the initial experience with CTG+ST+FBS indicated that sufficient 
information was available from CTG+ST provided the basic requirements for ST 
analysis were met. At the same time it should be recognised that FBS may be part of 
the learning-curve with less cases requiring FBS over time.
Non-reassuring CTG at start of ST analysis 
Another aspect of particular interest was the relationship between FBS and ST in 
those cases where CTG changes were noted already at onset of the recording. Even 
though CTG changes were noted at onset, CTG+ST guidelines indicated abnormality 
prior to an abnormal FBS in 14 out of 17 cases. The duration between CTG+ST 
indications to intervene and an abnormal FBS was in median 29  minutes (range 11-
74,  95% CI). Of those three cases not identified, two were late onset of the recording 
in second stage and the third had an FBS obtained nine minutes before a normal 
vaginal delivery in connection with bradycardia and uterine rupture (cord artery pH 
6.97, pCO2 15.0 kPa, BDecf 5.0 mmol/l, normal neonatal period). 
Continuing documentation – seven years of ST analysis usage
Most recently, two papers were presented providing each seven years of detailed 
outcome analysis of CTG+ST usage. In the first, Norén and Carlsson (2008)  presented 
the outcome of CTG+ST usage at Mölndal Hospital. The data covering 22171 term 
deliveries in active labour showed a marked reduction in cord metabolic acidosis rate 
in the total population from 0.72% in 2001 to 0.06% in 2007 (p<0.001).
Table XII gives the findings related to cases where a non-reassuring FBS defined 
as scalp pH <7.20 or scalp lactate >4.7 mmol/l were obtained. Adequate recording 
with a non-reassuring FBS without CTG+ST indications was always associated with 
a normal perinatal outcome (no met acidosis and/or 5 minute Apgar >7). 
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Thus, the current data from the Mölndal Hospital show that marked decrease in 
metabolic acidosis rate was associated with:
Increased usage of CTG+ST reaching 70%.  –
Ability to identify adverse FHR patterns at onset of a recording (lack of  –
reactivity and variability and cases with unstable baseline FHR).
Ability to respond in time to CTG+ST information (a slow response rate as a  –
cause of metabolic acidosis was found to decrease from 0.75% to 0.09% of all 
CTG+ST recordings, p<0.001).
Improved knowledge among staff with regard to CTG+ST assessment due  –
to bedside guidance,  repeated teaching sessions in CTG interpretation and 
intrapartum clinical management as well as the introduction of clinical audit 
in cases of severe intrapartum asphyxia.
Improvements in FECG (STAN) technology. –
Additional information from FBS was useful;
When ST analysis was started in second stage.  –
When the CTG showed unstable baseline FHR at onset.  –
In case of no ST data being available.  –
The second study contains data from the University of Turku (Timonen 2008). 
During the last three years and 2040 deliveries monitored with CTG+ST there was 
only one case with metabolic acidosis (VE for CTG+ST changes, normal neonatal 
outcome), despite a relatively low operative delivery rate. In the total population, the 
rate of acidaemia (cord artery pH <7.05) showed a steady decline from 1.5% to 0.7% 
(OR 0.43, 95%CI 0.27-0.69) at the same time as the FBS rate decreased from the low 
rate of 1.7% to 0.4% (OR 0.20, 0.14-0.29, p<0.0001). 
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In summary
Automated ST analysis requires a steady-state situation at onset (a stable baseline 
and a non-deteriorating FHR pattern) as well as continuous signs of a fetus capable 
of responding, i.e. signs of reactivity and variability. Provided these prerequisites are 
fulfilled, the metabolic myocardial stress can be captured identifying the onset of 
anaerobic metabolism. This enables intrapartum hypoxia to be identified in a timely 
manner well in advance of asphyxia and in most cases no additional information 
from FBS is required. However, it has to be emphasized that in the trials included 
in this thesis,  FBS has been used as a complementary methodology and we still 
lack studies directly evaluating the additional value of FBS, i.e. comparing CTG+ST 
versus CTG+ST+FBS. The contribution of metabolic acidosis  to the lowering of 
pH is marginal compared to the load of free hydrogen ions caused by accumulation 
of CO2. This means that the metabolic component may present itself at different pH 
levels but the lower the pH, the more likely it is that there is a metabolic acidosis 
component being added.
What are the exceptions?
Although hypoxia is the most common reason for an adverse outcome of labour, 
dystocia with related trauma, fetal bleeding and intrauterine infections are also 
known causes of an adverse outcome where the relationship between fetal pH and 
ST changes may be different. Recently, a three cases report was published from 
Westerhuis et al 2007. The detailed review identified poor signal quality, difficulties 
in CTG interpretation, failure to comply with CTG+ST clinical guidelines and 
deterioration of the CTG without ST events as the leading causes of these adverse 
outcomes.  Interestingly, the report caused Letters-to-the Editor arguing that these 
cases required additional analysis and ST analysis was not to blame  (Ugwumadu 
2008, Poddar 2008).
All of these cases had preterminal FHR patterns for different reasons, group-B 
Streptococcus infection, fetal myocardial dystrophy and maternal hyperventilation 
causing prolonged QT-intervall (Gyselaers et al 2007).  This illustrates the fact 
that fetal surveillance during labour should be about recognising each fetus as an 
individual and trying to assess the pattern of response (biopattern) associated with 
each fetus. The current development of residuals to provide on-line information 
on fetal reactivity features, should be seen as a development along the lines of 
quantifying fetal reactivity as a key biopattern feature  (Rosén et al 2007).
Inflammatory reactions in combination with hypoxia are known to cause 
increased vulnerability of the developing brain (Eklind et al 2001) and it is of interest 
to note that the increase in heart rate variability and ST depression/negative T waves 
associated with infusion of the bacterial cell fragment  lipopolysaccharide in the 
preterm fetal lamb (Blad et al 2008).
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Concluding remarks
Fetal surveillance in labour relates to basic (acid base) biochemistry as well as 
to modern computing and artificial intelligence. Only by working towards improved 
understanding of mechanisms involved with fetal reactions, or lack of reactions, 
would we be able to reduce ambiguity, improve and resolve negligence and medico-
legal issues. ST analysis of the FECG has been through a rigorous development 
progress that delivers improved care in perinatal centres keen to participate and 
adapt. As with all methodologies, nothing is achieved by a piece of machinery, it is 
the educated monitor using the machinery that makes the difference.
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Sammanfattning
Förmågan att rätt bedöma fostrets tillstånd under förlossningen är en utmaning. Vedertagen 
metod har varit att lyssna på fostrets hjärtfrekvens med stetoskop och, sedan 1970-talet, 
kontinuerligt följa hjärtfrekvensen med cardiotocografi (CTG). Dock har försök utförda både på 
djur och människa visat att syrebrist under förlossningen kan förändra utseendet på fosters EKG 
så att en höjning av ”T vågen” och en sänkning av ”ST sträckan” har noterats. En ny medicinsk 
utrustning (STAN Neoventa Medical, Mölndal) har utvecklats för att analysera foster EKG 
under förlossningen. I flera randomiserade studier har kombinationen av konventionell CTG 
tillsammans med analys av ST sträckan visat på lägre frekvens syrebrist hos nyfödda samtidigt 
som andelen instrumentella förlossningar (kejsarsnitt, tång och sugklocka) kunnat minskas. 
Avhandlingens syfte har varit att se hur denna fosterövervakningsteknik har kunnat 
genomföras i klinisk praxis. På Sahlgrenska sjukhuset i Göteborg har under en period av två år 
4830 av totalt 14687 (32,9%) fullgångna graviditeter i aktivt värkarbete följts med ST analys 
som komplement till CTG. Andelen patienter som övervakades första året var 28,1% och år två 
37,7%. En sänkning av andelen barn med syrebrist från 0,76% till 0,44% kunde konstateras 
hos alla barn under studietiden. I den grupp som var belastad med riskförlossningar och därför 
följts med ST analys förutom CTG var sänkningen från 1,12% till 0,56%. Andelen operativa 
förlossningar förändrades ej.
En motsvarande undersökning har utförts på förlossningen i Varberg (år 2004 och 2005). 
Under denna tid övervakades 59% (1875/3193) med ST analys förutom CTG. Andelen foster 
med syrebrist var 0,5% av alla förlösta.
Man kan konstatera att andelen foster med syrebrist i denna stora grupp patienter från 
Göteborg och Varberg (14687+3193) var minst lika låg som tidigare påvisats i gruppen med 
CTG+ST analys i den svenska randomiserade studien (Amer-Wåhlin et al 2001).
Fosterblod taget från skalpen (FBS) för analys av pH är ett vedertaget komplement till CTG 
under förlossning. Utifrån ett material från en europeisk multicenterstudie (omfattande 6999 
patienter) angående införandet av ST analys i kliniken, identifierades 911 fall där skalp pH hade 
tagits.
De flesta (73%) av FBS togs under värkarbetets sista timma för att verifiera CTG och ST 
förändring.  I 14 av de 15 fall med svår syrebrist i navelartären och där barnen togs till neonatal 
avdelning för observation hade CTG+ST analys indikerat nödvändigheten att förlösa i minst 19 
minuter. I de fall förlossning ägde rum inom 16 minuter efter att CTG+ST analys visat patologi 
sågs i 61% (17/28) navelartär pH >7,20 medan om förlossning skedde efter mer än 16 min hade 
19% pH >7,20.
Av de 911 fall där FBS tagits fanns 53 foster som hade pH<7,06 och 44 foster som hade pH 
mellan 7,06 och 7,09 i navelsträngsartären. I 44/53 fall sågs signifikanta ST förändringar och 
i två fall var CTG kurvan preterminal (utan reaktion). I fem fall kunde inte CTG+ST analys 
bedömas fram till 20 minuter innan förlossning och i fem fall visade CTG+ST analys inga 
indikationer att ingripa. Ett av dessa fall hade svår syrebrist. I pH 7,06-7,09 gruppen indikerade 
ST analysen skäl att ingripa i 24 fall. Av de 20 fall utan ST analys förändring hade alla Apgar 
minst sju, utom ett barn som förlöstes med sugklocka. Detta barn hämtade sig snabbt.
I fall av patologiskt CTG och skalp pH <7,20 identifierade ST analys abnormitet före FBS i 
alla fall utom sju. Ingen av dessa sju fall hade senare svår syrebrist. I två % av fallen sågs falskt 
positiv ST analys.
Sammanfattningsvis pekar dessa studier på att fosterövervakning med ST analys av foster 
EKG även i klinisk praxis kan minska antalet barn som föds med syrebrist och att ST analys 
liksom FBS är ett bra komplement.
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